ETON vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

ETON

40.3
AI Score
VS
PCRX Wins

PCRX

58.6
AI Score

Investment Advisor Scores

ETON

40score
Recommendation
HOLD

PCRX

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ETON PCRX Winner
Revenue 61.85M 369.77M PCRX
Net Income 13.13M 7.57M ETON
Net Margin 21.2% 2.0% ETON
Operating Income 15.21M 11.17M ETON
ROE 28.2% 1.1% ETON
ROA 11.3% 0.6% ETON
Total Assets 115.81M 1.24B PCRX
Cash 26.84M 205.88M PCRX
Debt/Equity 0.41 0.54 ETON
Current Ratio 1.52 5.04 PCRX
Free Cash Flow 14.59M 79.08M PCRX

Relative Price Performance (Last 90 Days)

ETON 1M: +43.8% · 3M: +81.3% PCRX 1M: -4.9% · 3M: +5.1%

Current Technical Phase

ETON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (22.0% over 20 days), RSI 74

RSI (14): 73.6 · Price: $63.47

PCRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.5 · Price: $24.67

Fundamentals Snapshot

Metric ETON PCRX
Market Cap
Forward P/E 24.6 6.9
Trailing P/E 157.7 67.7
Revenue (TTM)
Revenue Growth 1.0% 0.1%
Gross Margin 0.6% 0.8%
Operating Margin 0.4% 0.1%
EPS 0.38 0.36
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.